Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2 years of age and younger.

导出 OA

翻译打印收藏纠错

第一作者： Chetan C,Shah

第一单位： Pediatric Radiology, Wolfson Children's Hospital, Nemours Children's Health System, 800 Prudential Drive, Jacksonville, FL, 32207, USA. Chetan.Shah@nemours.org.

作者： Chetan C,Shah ^[1] ; Maria Vittoria,Spampinato ^[2] ; Hemant A,Parmar ^[3] ; Osama A,Raslan ^[4] ; Paolo,Tomà ^[5] ; Doris D M,Lin ^[6] ; Josef,Vymazal ^[7] ; Cesare,Colosimo ^[8] ; David S,Enterline ^[9]

作者单位： Pediatric Radiology, Wolfson Children's Hospital, Nemours Children's Health System, 800 Prudential Drive, Jacksonville, FL, 32207, USA. Chetan.Shah@nemours.org. ^[1] Medical University of South Carolina, Charleston, SC, USA. ^[2] C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA. ^[3] Davis Medical Center, University of California, Sacramento, CA, USA. ^[4] Bambino Gesù Children's Hospital, Rome, Italy. ^[5] Johns Hopkins University School of Medicine, Baltimore, MD, USA. ^[6] Department of Radiology, Na Homolce Hospital, Prague, Czech Republic. ^[7] Insitute of Radiology, Radiodiagnostica e Neuroradiologia, Fondazione Policlinico Universitario "A. Gemelli," Universita Cattolica del Sacro Cuore, Rome, Italy. ^[8] Duke University School of Medicine, Durham, NC, USA. ^[9]

关键词 Central nervous system Children Contrast Diagnostic efficacy Gadolinium-based contrast agent Gadoteridol Magnetic resonance imaging Safety